Literature DB >> 27190423

Anti-human immunodeficiency virus serology status and pre- and post-test counseling: A note.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Year:  2016        PMID: 27190423      PMCID: PMC4857694          DOI: 10.4103/0253-7184.176221

Source DB:  PubMed          Journal:  Indian J Sex Transm Dis AIDS        ISSN: 2589-0557


× No keyword cloud information.
Sir, The anti-human immunodeficiency virus (HIV) serology test is the widely laboratory investigation worldwide. The test is considered a confidential investigation, and the privacy is very important. The specific process for testing is needed. Pre- and post-test counseling is the basic practice.[1] Here, the authors summarize and report the information on anti-HIV serology status and pre- and post-test counseling within 1-year period, 2012, in a local healthcare center in Bangkok, Thailand. From overall, 2257 cases requesting for investigation and getting pretest counseling, only 2232 cases (98.9%) permitted to receive the anti-HIV serological test. From 2232 cases receiving the investigation, 1824 (81.7%) were seronegative (432 [194%] were in the window period) and 408 (18.3%) were seropositive. From these 2232 cases, only 1873 cases (83.9%) got posttest counseling. Focusing on posttest counseling, 79.6% of cases with seropositivity and 80.3% of cases with seronegativity got the counseling (but 1.64% of those with seronegativity and within window period got the posttest counseling). Based on this data, it can be seen that the problem in the lack of posttest counseling is not uncommon, and the problem is more frequent in the cases with seronegativity. Of interest, those with seronegativity and within window period usually get no posttest counseling. It is needed to find a method to increase the coverage of posttest counseling.[2]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest
  2 in total

Review 1.  Reconsidering HIV testing--consent is still the key.

Authors:  Francis J Bowden
Journal:  Sex Health       Date:  2005       Impact factor: 2.706

2.  Quality, not just quantity: lessons learned from HIV testing in Salvador, Brazil.

Authors:  Sarah MacCarthy; Jennifer J K Rasanathan; Ines Dourado; Sofia Gruskin
Journal:  Glob Public Health       Date:  2014-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.